These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 1670994)
21. p53 gene mutation spectrum in hepatocellular carcinoma. Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291 [TBL] [Abstract][Full Text] [Related]
22. Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. Hatada I; Tokino T; Ochiya T; Matsubara K Oncogene; 1988 Nov; 3(5):537-40. PubMed ID: 2856253 [TBL] [Abstract][Full Text] [Related]
23. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Simon D; Knowles BB; Weith A Oncogene; 1991 May; 6(5):765-70. PubMed ID: 1646986 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Minami M; Daimon Y; Mori K; Takashima H; Nakajima T; Itoh Y; Okanoue T Oncogene; 2005 Jun; 24(27):4340-8. PubMed ID: 15806150 [TBL] [Abstract][Full Text] [Related]
26. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas]. Shao J; Li X; Liu Z Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437 [TBL] [Abstract][Full Text] [Related]
27. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260 [TBL] [Abstract][Full Text] [Related]
28. [Molecular aspects of human hepatocellular carcinoma]. Imamura T; Matsubara K Gan To Kagaku Ryoho; 1989 Jan; 16(1):18-24. PubMed ID: 2536267 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882 [TBL] [Abstract][Full Text] [Related]
30. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
31. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820 [TBL] [Abstract][Full Text] [Related]
33. LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma. Yan J; Yu Y; Wang N; Chang Y; Ying H; Liu W; He J; Li S; Jiang W; Li Y; Liu H; Wang H; Xu Y Oncogene; 2004 Mar; 23(10):1939-49. PubMed ID: 14981537 [TBL] [Abstract][Full Text] [Related]
34. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma]. Wang XH; Wang PL Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962 [TBL] [Abstract][Full Text] [Related]
35. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Emi M; Fujiwara Y; Nakajima T; Tsuchiya E; Tsuda H; Hirohashi S; Maeda Y; Tsuruta K; Miyaki M; Nakamura Y Cancer Res; 1992 Oct; 52(19):5368-72. PubMed ID: 1356616 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711 [TBL] [Abstract][Full Text] [Related]
37. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Matsubara K; Tokino T Mol Biol Med; 1990 Jun; 7(3):243-60. PubMed ID: 2170810 [TBL] [Abstract][Full Text] [Related]
38. Deletion of integrated hepatitis B virus genome and cellular flanking sequences in hepatocellular carcinoma cells in BALB/c mice. Chang PC; Hu CP; Chen SH; Wang-Wuu S; Chang C Hepatology; 1995 Jun; 21(6):1504-9. PubMed ID: 7768493 [TBL] [Abstract][Full Text] [Related]
39. Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA. Tamori A; Yamanishi Y; Kawashima S; Kanehisa M; Enomoto M; Tanaka H; Kubo S; Shiomi S; Nishiguchi S Clin Cancer Res; 2005 Aug; 11(16):5821-6. PubMed ID: 16115921 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Dejean A; Bougueleret L; Grzeschik KH; Tiollais P Nature; 1986 Jul 3-9; 322(6074):70-2. PubMed ID: 3014347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]